Allergic diseases is an umbrella term used to describe a variety of immune-mediated diseases that vary mechanistically. Common elements include a breakdown of immunologic tolerance, a biased type 2 immune response, and an impaired epithelial barrier with chronic nature. Allergies are influenced by diverse factors such as diet, infections, exposure to antibiotics and chemicals, microbiome composition, and genetic and epigenetic elements. The complexity of these diseases, makes the treatment of allergic diseases particularly challenging. The aim of this research topic is to address the current advances and challenges in applying multiple levels of patient-specific data to tailor diagnoses and available treatments to the individual.
Below are examples of suitable themes for manuscripts. All submissions must be focused on the precision medicine approach to treating allergic diseases. All manuscripts types accepted by the Therapies, Therapeutic Targets and Mechanisms Section are welcome.
• Latest breakthroughs on molecular mechanisms underlying allergic diseases and prospective treatments.
• The contribution of environmental, genetic and epigenetic factors to the complexity of allergic diseases.
• Latest advances in treating allergic diseases.
• Identification of allergic diseases endotypes.
• Improved diagnostic methods of allergic disease.
• Interpretations of large data set and actionable multi-omics integration.
Conflict of interest declaration: Dr. Azouz is collaborating with Serpin Pharma, with no equity interest, royalty or financial benefit. Dr. Azouz is an inventor of a licensed patent owned by Cincinnati Children’s Hospital number of 63/017,027, and for the filed patent applications with the provisional number 63/107,571 and 17/302,247.
Allergic diseases is an umbrella term used to describe a variety of immune-mediated diseases that vary mechanistically. Common elements include a breakdown of immunologic tolerance, a biased type 2 immune response, and an impaired epithelial barrier with chronic nature. Allergies are influenced by diverse factors such as diet, infections, exposure to antibiotics and chemicals, microbiome composition, and genetic and epigenetic elements. The complexity of these diseases, makes the treatment of allergic diseases particularly challenging. The aim of this research topic is to address the current advances and challenges in applying multiple levels of patient-specific data to tailor diagnoses and available treatments to the individual.
Below are examples of suitable themes for manuscripts. All submissions must be focused on the precision medicine approach to treating allergic diseases. All manuscripts types accepted by the Therapies, Therapeutic Targets and Mechanisms Section are welcome.
• Latest breakthroughs on molecular mechanisms underlying allergic diseases and prospective treatments.
• The contribution of environmental, genetic and epigenetic factors to the complexity of allergic diseases.
• Latest advances in treating allergic diseases.
• Identification of allergic diseases endotypes.
• Improved diagnostic methods of allergic disease.
• Interpretations of large data set and actionable multi-omics integration.
Conflict of interest declaration: Dr. Azouz is collaborating with Serpin Pharma, with no equity interest, royalty or financial benefit. Dr. Azouz is an inventor of a licensed patent owned by Cincinnati Children’s Hospital number of 63/017,027, and for the filed patent applications with the provisional number 63/107,571 and 17/302,247.